Peptide-based vaccines for cancer: Are we choosing the right peptides?

Expert Review of Vaccines

Volumn 8, Issue 3, 2009, Pages 259-260

  Apostolopoulos, Vasso ^a  

^a BURNET INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; PEPTIDE VACCINE; SUBUNIT VACCINE;

CANCER IMMUNIZATION; DRUG RESEARCH; EDITORIAL; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; VACCINE PRODUCTION; IMMUNOLOGY; NEOPLASM;

CANCER VACCINES; HUMANS; NEOPLASMS; VACCINES, SUBUNIT;

EID: 63849178938     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.8.3.259     Document Type: Editorial

References (9)

1. Rammensee H, Friede T, Stevanovic S. MHC ligands and peptide motifs: first listing. Immunogenetics 41, 178-228 (1995).
2. Apostolopoulos V, Haurum JS, McKenzie IF. MUC1 peptide epitopes associated with 5 different H2 class I molecules. Eur. J. Immunol. 27, 2579-2587 (1997).
3. Apostolopoulos V, Karanikas V, Haurum J, McKenzie IF. Induction of HLA-A2 restricted cytotoxic T lymphocytes to the MUC1 human breast cancer antigen. J. Immunol. 159, 5211-5218 (1997).
4. Apostolopoulos V, Chelvanayagam G, Xing PX, McKenzie IF. Anti-MUC1 antibodies react directly with MUC1 peptides presented by class I H2 and HLA molecules. J. Immunol. 161, 767-775 (1998).
5. Apostolopoulos V, Yu M, Corper AL et al. Crystal structure of a non-canonical low affinity peptide complexed with MHC class I: a new approach for vaccine design. J. Mol. Biol. 318, 1293-1305 (2002).
6. Apostolopoulos V, Yu M, Corper AL et al. Crystal structure of a non-canonical high affinity peptide complexed with MHC class I: a novel use of alternative anchors. J. Mol. Biol. 318, 1307-1316 (2002).
7. Apostolopoulos V, Yuriev E, Ramsland PA, Plebanski M, Paulsen H, McKenzie IF. A glycopeptide in complex with MHC class I uses the GalNAc residue as an anchor. Proc. Natl Acad. Sci. USA 100, 15029-15034 (2003).
8. Lazoura E, Lodding J, Farrugia W, Day S, Ramsland PA, Apostolopoulos V. Non-canonical anchor motif peptides bound to MHC class I induce cellular responses. Mol. Immunol. DOI: 10.1016/j.molimm.2008.11.007 (2008) (Epub ahead of print).
9. Lazoura E, Lodding J, Farrugia W et al. Enhanced class I binding and immune responses through anchor modification of the non-canonical tumour associated MUC1-8 peptide. Immunology 119, 306-316 (2006).